Reimbursement

shutterstock_107572736

Labor’s Cancer Care Policy and the Australian Constitution

By Sarah Griffin | 1 May, 2019
The Australian Constitution and Labor’s Cancer Care Policy. As we ever so slowly move towards the Australian Federal Election, both major parties are presenting their health policies. Labor has promised...
Distribution copy

The commercialization continuum: beyond product registrations

By Luis Jimenez | 4 March, 2019
Your product is approved, now what? This is a question that can bring a painful realization to medical technology manufacturers and suppliers eagerly entering a new market. The appropriate preparation...
shutterstock_88704472

Cardiac Ablation Catheters included on the March 2019 Prostheses List

By Sarah Griffin | 1 March, 2019
The Prostheses List is a list of implantable medical devices for which Australian private health insurers must pay a specific benefit over and above any payment for the associated hospital...

Search

Recent Posts

Harmonised Standards for MDR? CEN/CENELEC say “Non”

Jul 2, 2020

FAQs Regarding the Australian R&D Tax Incentive and Regulatory Services

Jul 1, 2020

Addendum to TGA Deadlines: Medicine Labelling Compliance and COVID-19

Jun 19, 2020

Proposed delayed commencement of certain Medical Device Regulatory Changes

Jun 12, 2020

Software as a Medical Device – Upcoming Changes to the Australian Regulations

May 29, 2020

Keeping it Clean: Regulation of Hand Sanitisers as Cosmetics or Therapeutic Goods

May 19, 2020

Categories

Categories

Archives

Archives

Archives

Tags

510(k) APAC Australia Biocompatibility Brexit CE CE Certificates clinical trials coronavirus COVID19 de novo distribution EU Europe FDA GHTF Harmonization IMDRF IVD IVDD IVDR MDD MDR MDSAP medical device Medical Device Regulations medical devices medicines MHRA New Zealand Notified Bodies PMA PMDA postmarket private health insurance QMS Quality Systems Reform regulatory Reimbursement SaMD Software standards TGA UDI